OpenVSafe by OpenVAERS
Search V-safe

96E-18826-28650

1 vaccination 2 coded responses 3 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
741 / OK
Registered
2021-03-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-25
    Dose 1 — Moderna
  2. 2021-03-11
    Registered in v-safe
  3. 2021-03-11
    Survey response — day 14, dose 1
    MedDRA: Injection site discolouration, Injection site pain, Injection site pruritus, Injection site rash, Injection site swelling, Injection site urticaria, Rash erythematous — Feeling: Fair
    Free text: Rash at injection site 8 days following the injection. Approximately 2 x 3 inches. Began as red bumps, spread into large red area, became red ring. Also developed brown, scaly spot presumably where shot was administered. Itchy, swollen, sore.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-18
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  5. 2021-08-26
    Survey response — 6 months, dose 1
    MedDRA: Diffuse alopecia, Injection site rash, Menstruation irregular — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: I continue to have rashes at and near to my injection sites. I have also experienced menstrual changes and telogen effluviums directly following both vaccines.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  6. 2021-08-26
    Report sent to call center — 6 months, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-09-01

Vaccinations

DoseDateManufacturerCo-administered
12021-02-25Moderna

Call center

1 call center case

1 unsuccessful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 5 — day 14, dose 1

2021-03-11

Symptoms: Rash at injection site 8 days following the injection. Approximately 2 x 3 inches. Began as red bumps, spread into large red area, became red ring. Also developed brown, scaly spot presumably where shot was administered. Itchy, swollen, sore.

Release 9 — 6 months, dose 1

2021-08-26

Symptoms: I continue to have rashes at and near to my injection sites. I have also experienced menstrual changes and telogen effluviums directly following both vaccines.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDiffuse alopecia ✓ · ✓
SDInjection site discolouration ✓ ✓ ✓
SDInjection site pain ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDInjection site rash ✓ ✓ ✓
SDInjection site swelling ✓ ✓ ✓
SDInjection site urticaria ✓ ✓ ✓
SDMenstruation irregular ✓ · ✓
SDRash erythematous ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release